ITPR2 Protein (AA 1-287) (His tag)
-
- Antigène Voir toutes ITPR2 Protéines
- ITPR2 (Inositol 1,4,5-Trisphosphate Receptor, Type 2 (ITPR2))
- Type de proteíne
- Recombinant
- Attributs du protein
- AA 1-287
-
Origine
- Humain
-
Source
- Escherichia coli (E. coli)
- Purification/Conjugué
- Cette ITPR2 protéine est marqué à la His tag.
- Application
- Western Blotting (WB), SDS-PAGE (SDS), Positive Control (PC), Immunogen (Imm)
- Séquence
- Met1-Val287
- Attributs du produit
- Recombinant Inositol-1,4,5-Trisphosphate Receptor Type 2 (ITPR2), Prokaryotic expression, Met1-Val287, N-terminal His Tag
- Pureté
- > 90 %
- Top Product
- Discover our top product ITPR2 Protéine
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Commentaires
-
Isoelectric Point:8.7
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- PBS, pH 7.4, containing 0.01 % SKL, 1 mM DTT, 5 % Trehalose and Proclin300.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-80 °C
- Stockage commentaire
- Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.
- Date de péremption
- 12 months
-
- Antigène
- ITPR2 (Inositol 1,4,5-Trisphosphate Receptor, Type 2 (ITPR2))
- Autre désignation
- Inositol-1,4,5-Trisphosphate Receptor Type 2 (ITPR2 Produits)
- Synonymes
- AI649341 Protein, InsP3R-2 Protein, InsP3R-5 Protein, Ip3r2 Protein, Itpr5 Protein, insP3R2 Protein, IP3R2 Protein, inositol 1,4,5-trisphosphate receptor type 2 Protein, inositol 1,4,5-triphosphate receptor 2 Protein, inositol 1,4,5-trisphosphate receptor, type 2 Protein, ITPR2 Protein, Itpr2 Protein
- Sujet
- IP3R2, IP3 receptor isoform 2, Type 2 inositol 1,4,5-trisphosphate receptor, Type 2 InsP3 receptor
- Poids moléculaire
- 38kDa
- UniProt
- Q14571
- Pathways
- Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma
-